AO S.Andrea, Università degli Studi di Roma La Sapienza

Roma 189

0 studies enrolling now · 3 studies all time

What they study most

HER-2 Positive Breast Cancer, Metastatic Neoplasm, Multiple Sclerosis, Myelodysplastic Syndromes

Studies at this site

• Study to Evaluate Imetelstat (GRN163L) in Participants With International Prognostic Scoring System (IPSS) Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS) — Running, not enrolling
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) — Stopped early